PlainPharmaWatch

CMS Open Payments · Program Year 2024

Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc. reported $1,727,803.25 in payments to 159 physicians and teaching hospitals across 638 transactions.

See the rankings → How this is sourced
$1.7M
Total payments
638
Transactions
159
Recipients
+$133.4K
General Payments vs PY2023

Y-mAbs Therapeutics, Inc. reported $1,727,803.25 in payments to 159 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #485 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $10.9K per recipient across 3 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Y-mAbs Therapeutics, Inc. pairs above-median payment volume with a moderately concentrated payment pattern.

#485
of 1,925 companies
0.0%
of all US industry payments
0.5%
paid to its single top recipient
3
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Y-mAbs Therapeutics, Inc.'s CMS-reported General Payments increased by $133.4K (+176.9%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: Y-MABS THERAPEUTICS, INC.PY2023: Y-MABS THERAPEUTICS, INC.PY2024: Y-mAbs Therapeutics, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$75.4KPY2024$208.8K
PY2023
$75,412.47
PY2024
$208,819.07

How Y-mAbs Therapeutics, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Y-mAbs Therapeutics, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,727,803 Top 25% higher than 75% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Y-mAbs Therapeutics, Inc.

Averaging $2.7K per transaction and $10.9K per recipient, Y-mAbs Therapeutics, Inc.'s Program Year 2024 total comes to $1,727,803.25 across 638 transactions and 159 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #485 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 3 general-payment categories charted below, "Consulting Fee" is the largest at $196.8K across 24 transactions, 11.4% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 3 types of general payments, Y-mAbs Therapeutics, Inc.'s largest category was "Consulting Fee" at $196.8K - 11.4% of the company's reported total.

How Y-mAbs Therapeutics, Inc. divides its payments

How the reported total splits across payment categories

1. Consulting Fee$196.8K2. Food and Beverage$9.5K3. Grant$2.5K
Payment Type Amount Transactions
Consulting Fee $196.8K 24
Food and Beverage $9.5K 132
Grant $2.5K 3

Recipient Concentration in General Payments

The five largest recipient relationships account for $170,726.46 (81.8%) of $208,819.07 in this company's General Payments records across 130 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Y-mAbs Therapeutics, Inc.

The five named recipients with the highest reported General Payments from this company

Evgeniya Angelova$98.4KSteven Larson$27.8KHatice Gur$26.0KRoland Chu$9.5KLeonora Rose Slatnick$9.0K
  1. 1

    Evgeniya Angelova

    $98,400.00 across 4 reported transactions

  2. 2

    Steven Larson

    $27,775.00 across 4 reported transactions

  3. 3

    Hatice Gur

    $26,000.00 across 1 reported transactions

  4. 4

    Roland Chu

    $9,533.24 across 3 reported transactions

  5. 5

    Leonora Rose Slatnick

    $9,018.22 across 4 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $2.7K. Average per recipient: $10.9K.

Total Amount

$1,727,803.25

Avg per Transaction

$2.7K

Avg per Recipient

$10.9K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Y-mAbs Therapeutics, Inc. Share

0.0%

#485 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Y-mAbs Therapeutics, Inc.

Pharmacosmos Therapeutics Inc.

$1.7M 7,020 recipients

Dompe US, Inc.

$1.7M 11,308 recipients

Esperion Therapeutics, Inc.

$1.7M 27,251 recipients

Radiometer America, Inc

$1.7M 84 recipients

bioMerieux Inc

$1.7M 600 recipients

Medivation LLC.

$1.7M 3 recipients

Frequently Asked Questions

How much did Y-mAbs Therapeutics, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $1,727,803.25 from Y-mAbs Therapeutics, Inc. to physicians and hospitals across 638 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Y-mAbs Therapeutics, Inc.? ▾
Y-mAbs Therapeutics, Inc. made payments to 159 physicians and teaching hospitals in 2024. The average payment per recipient was $10.9K.
What types of payments did Y-mAbs Therapeutics, Inc. make? ▾
Y-mAbs Therapeutics, Inc. made 3 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Consulting Fee" at $196.8K, representing 11.4% of the company's reported total.
How does Y-mAbs Therapeutics, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Y-mAbs Therapeutics, Inc. sits at #485 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Y-mAbs Therapeutics, Inc.? ▾
Y-mAbs Therapeutics, Inc.'s 638 transactions to 159 recipients in 2024 averaged $2.7K per transaction.
Where does the payment data for Y-mAbs Therapeutics, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Y-mAbs Therapeutics, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.